TELA Bio (TELA) Net Shares Issued and Repurchased (2018 - 2026)
TELA Bio (TELA) posted Net Shares Issued and Repurchased of $960750.0 for Q1 2026, up 20.36% on a QoQ basis from $798200.0 in Q4 2025, and up 120.96% year-over-year from $434800.0 in Q1 2025.
Powered by 
Analysis
TELA Bio (TELA) Net Shares Issued and Repurchased (2018 - 2026) Analysis & Trends
TELA Bio has reported Net Shares Issued and Repurchased for 9 years, with the latest figure at $960750.0 in Q1 2026.
- On a quarterly basis, Net Shares Issued and Repurchased rose 120.96% year-over-year to $960750.0 in Q1 2026; TTM through Mar 2026 was $960750.0, a 120.96% increase from a year earlier, with the FY2025 full-year figure at $798200.0, up 201.5% from the prior year.
- Net Shares Issued and Repurchased was $960750.0 for Q1 2026 at TELA Bio, up from $798200.0 in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $960750.0 in Q1 2026, with the low at $180800.0 in Q1 2023.
- Average Net Shares Issued and Repurchased over 5 years is $417937.1, with a median of $264739.0 recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Net Shares Issued and Repurchased slumped 52.72% in 2023, then surged 201.5% in 2025.
- Over 5 years, Net Shares Issued and Repurchased stood at $450410.0 in 2022, then plunged by 52.72% to $212960.0 in 2023, then increased by 24.31% to $264739.0 in 2024, then soared by 201.5% to $798200.0 in 2025, then gained by 20.36% to $960750.0 in 2026.
- The last three Net Shares Issued and Repurchased figures came in at $960750.0 (Q1 2026), $798200.0 (Q4 2025), and $434800.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | TELA Bio | 50.22 Mn | 19.80 Mn | 13.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 960,750.00 |
| Dec 31, 2025 | 798,200.00 |
| Mar 31, 2025 | 434,800.00 |
| Dec 31, 2024 | 264,739.00 |
| Mar 31, 2024 | 219,600.00 |
| Dec 31, 2023 | 212,960.00 |
| Mar 31, 2023 | 180,800.00 |
| Dec 31, 2022 | 450,410.00 |
| Mar 31, 2022 | 239,175.00 |
| Dec 31, 2021 | 468,000.00 |
| Mar 31, 2021 | 180,575.00 |
| Dec 31, 2020 | 175,086.00 |
| Mar 31, 2020 | 71,940.00 |
| Dec 31, 2019 | 978,415.00 |
| Dec 31, 2018 | 152,016.00 |